The gatekeeper residue controls autoactivation of ERK2 via a pathway of intramolecular connectivity
Open Access
- 28 November 2006
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (48) , 18101-18106
- https://doi.org/10.1073/pnas.0608849103
Abstract
Studies of protein kinases have identified a “gatekeeper” residue, which confers selectivity for binding nucleotides and small-molecule inhibitors. We report that, in the MAP kinase ERK2, mutations at the gatekeeper residue unexpectedly lead to autoactivation due to enhanced autophosphorylation of regulatory Tyr and Thr sites within the activation lip that control kinase activity. This occurs through an intramolecular mechanism, indicating that the gatekeeper residue indirectly constrains flexibility at the activation lip, precluding access of the phosphoacceptor residues to the catalytic base. Other residues that interact with the gatekeeper site to form a hydrophobic cluster in the N-terminal domain also cause autoactivation when mutated. Hydrogen-exchange studies of a mutant within this cluster reveal perturbations in the conserved DFG motif, predicting a route for side chain connectivity from the hydrophobic cluster to the activation lip. Mutations of residues along this route support this model, explaining how information about the gatekeeper residue identity can be transmitted to the activation lip. Thus, an N-terminal hydrophobic cluster that includes the gatekeeper forms a novel structural unit, which functions to maintain the “off” state of ERK2 before cell signal activation.Keywords
This publication has 34 references indexed in Scilit:
- A Src-Like Inactive Conformation in the Abl Tyrosine Kinase DomainPLoS Biology, 2006
- A single amino-acid change in ERK1/2 makes the enzyme susceptible to PP1 derivativesBiochemical and Biophysical Research Communications, 2006
- Protein Kinase Inhibitors: Insights into Drug Design from StructureScience, 2004
- Constitutive Activation of Extracellular Signal-regulated Kinase 2 by Synergistic Point MutationsJournal of Biological Chemistry, 2001
- Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or AmplificationScience, 2001
- Isolation of Hyperactive Mutants of the MAPK p38/Hog1 That Are Independent of MAPK Kinase ActivationJournal of Biological Chemistry, 2001
- Activation Mechanism of the MAP Kinase ERK2 by Dual PhosphorylationCell, 1997
- Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activationCell, 1995
- Transformation of Mammalian Cells by Constitutively Active MAP Kinase KinaseScience, 1994
- Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cellsCell, 1994